Hims & Hers Health, Inc. (HIMS) vs Indivior Pharmaceuticals Inc. (INDV)
- Hims & Hers Health, Inc. HIMS 28.07 −4.46%
- Indivior Pharmaceuticals Inc. INDV 32.45 −3.48%
Hims & Hers Health, Inc. and Indivior Pharmaceuticals Inc. are both Drug Manufacturers Specialty & Generic companies. Hims & Hers Health, Inc. is the larger, with a market value of $6.9B against $4.0B — 1.7× the size. Hims & Hers Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Indivior Pharmaceuticals Inc. trades at 11.2×. Hims & Hers Health, Inc. grew revenue faster over the last twelve months: 28.0% against 13.5%. Indivior Pharmaceuticals Inc. has the higher net margin (26.8% vs −5.51%) and the higher return on invested capital (460.5% vs −11.4%). Across the 17 metrics below, Indivior Pharmaceuticals Inc. leads on 9 and Hims & Hers Health, Inc. on 8.
Valuation
Profitability
| Metric | HIMS | INDV | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 68.43% | 81.97% | 53.94% |
| Operating margin | (5.99%) | 31.56% | 0.00% |
| Net margin | (5.51%) | 26.75% | 0.00% |
| Free cash flow margin | 3.22% | (8.34%) | 0.00% |
| Return on equity | (32.03%) | (153.12%) | (0.40%) |
| Return on assets | (5.16%) | 26.52% | (3.32%) |
| Return on invested capital | (11.38%) | 460.53% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack